Clinical trial
Precision Assessment of Perioperative Effectiveness and Safety of Transthoracic Minimally Invasive Hybrid Closure for Pediatric Ventricular Septal Defects
NCT02794584 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Assessment of Perioperative Effectiveness and Safety of Transthoracic Minimally Invasive Hybrid Closure for Pediatric Ventricular Septal Defects
- Lead sponsor
- Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- December 31, 2016
- Enrollment
- 200 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pediatric ventricular septal defects